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ttp://dx.doi.org/10.1016/j.ajpath.2013.03.020Like the p16, SMAD4, and RB1 genes, FAM190A (alias CCSER1) lies at a consensus site of homogeneous
genomic deletions in human cancer. FAM190A transcripts in 40% of cancers also contain in-frame
deletions of evolutionarily conserved exons. Its gene function was unknown. We found an internal
deletion of the FAM190A gene in a pancreatic cancer having prominent focal multinuclearity. The
experimental knockdown of FAM190A expression by shRNA caused focal cytokinesis defects, multipolar
mitosis, and multinuclearity as observed in time-lapse microscopy. FAM190A was localized to the g-
tubulin ring complex of early mitosis and to the midbody in late cytokinesis by immunoﬂuorescence assay
and was present in the nuclear fraction of unsynchronized cells by immunoblot. FAM190A interacted with
EXOC1 and Ndel1, which function in cytoskeletal organization and the cell division cycle. Levels of
FAM190A protein peaked 12 hours after release from thymidine block, corresponding to M-phase. Slower-
migrating phosphorylated forms accumulated toward M-phase and disappeared after release from
a mitotic block and before cytokinesis. Studies of FAM190A alterations may provide mechanistic insights
into mitotic dysregulation and multinuclearity in cancer. We propose that FAM190A is a regulator or
structural component required for normal mitosis and that both the rare truncating mutations and
common in-frame deletion alteration of FAM190A may contribute to the chromosomal instability of
cancer. (Am J Pathol 2013, 183: 296e303; http://dx.doi.org/10.1016/j.ajpath.2013.03.020)Supported by NIH grants P01 CA134292, P50 CA62924, and RO1
CA128920 and by the Everett and Marjorie Kovler Professorship in
Pancreas Cancer Research.Chromosomal instability promotes the development of most
cancers. Somatic mutations in mitotic genes occur in some
human cancers, including mitotic checkpoint genes and
cohesins, but these accounts for <15% of all cancers.1e3
There is thus an unmet need to explain widespread aneu-
ploidy in cancers.
We previously reported a human pancreatic cancer with
focal prominent multinuclearity.4 Although the typical
mutations of pancreatic cancer would not be able to ex-
plain this phenotype, a high-throughput examination of
rearrangements revealed the tumor to have an out-of-frame
deletion of exons 4 and 5 of the FAM190A gene.5 This
mutation was unusual for FAM190A, perhaps representing
a more severe gene disruption than typically observed. We
previously reported that approximately 40% of the human
cancers have internal rearrangements (exon deletions)
in FAM190A transcripts,6 generally being in-frame and
affecting downstream exons. The FAM190A gene was not
silenced (we observed its transcripts) or lost in entirety.
FAM190A genomic homozygous deletions were also re-
ported in pancreatic cancer cell lines7 and in an esophagealstigative Pathology.
.cancer8 examined by a single-nucleotide array, and a
homozygous missense mutation was observed in a none
small cell lung cancer.9 FAM190A was associated with
attention-deﬁcit hyperactivity disorder in a genome-wide
association study, but after correction for multiple com-
parisons it was not statistically signiﬁcant.10
The FAM190A protein was notable in having 23 serines
among the ﬁrst 69 amino acids but had no other deﬁned
domains or known function. We induced FAM190A deﬁ-
ciency in cells, creating phenotype of focal multinuclearity
and multipolar mitosis, recalling the phenotype of the
described pancreatic cancer. The multinuclear phenotype
accompanied cellular defects in cytokinesis. We observed
phosphorylated forms of FAM190A in cells related to
stages of the division cycle. This work may provide a link
between FAM190A deletions and genomic abnormalities
of cancer.
FAM190A Absence Creates Mitosis DefectsMaterials and Methods
Biological Samples and Supplies
Xenografted human cancers were obtained from our
described tissue banks.11 Human tissue was also collected
through The Gastrointestinal Cancer Rapid Medical Dona-
tion Program at The Johns Hopkins Hospital. Tissues were
obtained and used under institutional review boarde
approved protocols. Selected pancreatic cancer xenografts
PX19-R2 and PX188-3 had FAM190A genomic deletions;
FAM190A genomic status was unknown for unselected
pancreatic xenografts PX120-4A and PX121-3.
All cell lines were from ATCC (Manassas, VA) except
AAV-293,whichwas fromAgilent Technologies (SantaClara,
CA). HeLa, DLD1, and AsPC1 cells had wild-type FAM190A
transcripts. AAV-293 cells had transcript deletions of exons 7
or 7, 8, and 9. RKO cells had a genomic homozygous deletion
of exons 4, 5, 6, and 7. H2126 had a genomic homozygous
deletion of exons 9 and 10. HeLa,RKO,H2126, andAAV-293
cells were grown inDulbecco’smodiﬁed Eagle’smedium, and
AsPC1 and DLD1 cells in RPMI 1640 medium, all with 10%
fetal bovine serum and antibiotics.
Dulbecco’s modiﬁed Eagle’s medium, Lipofectamine
2000, Lipofectamine, ProLong Gold antifade reagent with
DAPI, Celllight Green ﬂuorescent protein (GFP) histone 2B
(H2B), and 4% to 12% Bis-Tris acrylamide gels were from
Life Technologies Inc (Carlsbad, CA). Protease inhibitors
were from Roche (Basel, Switzerland). Thymidine, noco-
dazole, demecolcine, N-ethymaleimide, propidium iodide
(PI), Protein A-Sepharose, LabTek 8-well glass, and Per-
manox slides were from Sigma-Aldrich (St. Louis, MO).
Calf intestinal phosphatase (CIP) was used in restriction
enzyme buffer 3 (New England BioLabs, Ipswich, MA).
Rabbit anti-FAM190A monoclonal antibodies (mAbs)
mAb7, mAb62, mAb96, mAb108, and mAb170 were devel-
oped by immunizing rabbits with recombinant FAM190A
protein (performed by Epitomics Inc, Burlingame, CA). For
polyclonal anti-FAM190A antibodies, rabbits were immu-
nized with peptides of exons 7, 8, 9, and 10 of FAM190A
(performed by Creative Diagnostics, Shirley, NY). Exon-
speciﬁc polyclonal antibodies were puriﬁed from sera by
Protein A-Sepharose. Antieg-tubulin (GTU-88) antibody
was from Sigma-Aldrich. Antiea-tubulin (DM1A), antie
securin B, antielamin B, anti-actin, and anti-GAPDH
antibodies and horseradish peroxidaseetagged secondary
antibodies goat anti-mouse, goat anti-rabbit, and donkey
anti-goat were from Santa Cruz Biotechnology (Santa Cruz,
CA). Antiecentrin 3 was from Abnova (Tapei City, Japan).
Anti-FAM190A (AP10022b) was fromAbgent (San Diego,
CA). Antiecyclin E was from BD Biosciences (San
Jose, CA). Anti-Ndel1, anti-EXOC1, and anti-FAM190A
(ab90508) were from Abcam (Cambridge, UK). Horse-
radish peroxidaseetagged mouse monoclonal anti-rabbit
antibody was from Jackson ImmunoResearch Laboratories
Inc (West Grove, PA).The American Journal of Pathology - ajp.amjpathol.orgGeneration of FAM190A-Deﬁcient Cell Lines
Retroviral control, scrambled, and FAM190A-targeting
shRNA plasmids were from Origene Technologies (Rock-
ville, MD). FAM190A-targeting sequences were as follows:
plasmid 77, 50-TACCTGCTACAAGTGTGAGCCACTC-
AGAG-30; plasmid 78, 50-GCTCAACCTGGTCACAGCA-
ATATGCAGAA-30; plasmid 79, 50-ATGTGCCGCAGTA-
GTTCTTACTCCTATGG-30; plasmid 80, 50-CTCTGCCA-
TTCAGACTGATGTTACAGGAC-30; plasmid 96A, 50- TG-
AACTAGGTTGCATTGCCTTGAAGACTT-30; and plasmid
96B, 50- GTTGAAGTACCGTGACATAACACAAGGTG-30.
HeLa, AAV-293, RKO, AsPC1, and DLD1 cells were
transfected with shRNA plasmids or infected with retroviral
shRNA plasmid. New antibiotic-containing medium was
added to cultures 48 hours after transfection or infection.
Cells were selected with puromycin; stable clones were
established by colony-selection or limiting dilution.
Yeast Two-Hybrid
A yeast two-hybrid screen was performed (Hybrigenics
Services SAS, Paris, France) using full-length FAM190A as
bait and human fetal brain cDNA RP1 as the prey library.
Interactions (67.9 million) were recorded in the presence of
10 mmol/L 3-aminotriazole selection. For each interaction,
a predicted biological score was computed to assess the
interaction reliability. This score represents the probability
of an interaction to be nonspeciﬁc: it is an E-value primarily
comparing the number of independent prey fragments found
for an interaction and the chance of ﬁnding them at random
(background noise).
Cell Lysis, IB, and IP
Cells were lyzedwith detergent (150mmol/LNaCl, 50mmol/L
Tris-HCl, 1 mmol/L EDTA, 1% Triton-X, 20 mmol/L N-
ethymaleimide, pH 7.4) or RIPA solution (150 mmol/L NaCl,
50mmol/LTris-HCl, 1mmol/LEDTA,1%TritonX-100, 0.5%
sodiumdeoxycholate, 0.1%SDS, pH7.4). For immunoblotting
(IB), clariﬁed cell lysates were quantiﬁed by the DC method
(Bio-Rad Laboratories, Hercules, CA). Protein in Laemmli
buffer (20 to 40mg perwell) was loaded and resolved on 4% to
12% Bis-Tris gels, and transferred to a polyvinylidene
diﬂuoride membrane, blocked with 5% milk, incubated with
primary antibody and subsequently with horseradish perox-
idaseetagged secondary antibody, developed with chem-
iluminescence [Luminol from ThermoScientiﬁc (Rockford,
IL) or Luminata Forte from Millipore (Billerica, MA)], and
imaged on ﬁlm. For immunoprecipitation (IP), 1 mg of lysate
was incubated with 2 mg of antibodies; complexes were
captured by addition of Protein A-Sepharose and bound
proteins eluted by denaturation using 1 Laemmli buffer and
incubating at 100C for 5 minutes. Human tissues and xeno-
graftswere lyzed in lysis detergent containing1%SDS. For IP,
2 mg of tissue lysate was incubated with 10 mg of antibodies;297
Patel et alcomplexes were captured by addition of Protein A-Sephar-
ose and bound proteins eluted by denaturation using 1
Laemmli buffer and incubating at 100C for 5 minutes.
Cell Synchronization
Double-Thymidine Block
HeLa cells were treated with thymidine (5 mmol/L) for
16 hours. Washed cells were grown for 8 to 10 hours
without thymidine and then treated again with thymidine for
16 hours; thrice-washed cells were fed with fresh medium
and harvested at 0, 8, 10, 12, 14, and 16 hours in cell lysis
detergent or prepared for ﬂow cytometry. Protein (20 mg per
well) was examined by IB.
Thymidine-Nocodazole Block
HeLa cells were treated with 5 mmol/L thymidine for
16 hours. Washed cells were immediately treated with
medium containing 50 ng/mL of nocodazole for 16 hours.
Rounded cells were harvested at prometaphase by shake-off
and gentle pipetting. Washed cells were resuspended in
medium in a culture ﬂask and harvested at 0, 0.5, 1, 2, 4, 6,
and 24 hours in cell lysis detergent or for ﬂow cytometry.
Protein (20 mg per well) was examined by IB.
Flow Cytometry
Harvested cells were ﬁxed by slow addition of 70% ethanol
and stored at 20C until analysis. PI-stained cells were
analyzed in a ﬂow cytometer (FACSCalibur; BD Biosci-
ences, San Jose, CA). Data were analyzed with CellQuest
Pro version 5.2.1 software (BD Biosciences).
Immunoﬂuorescence
Cells were grown on 8-well slides, washed with PBS, ﬁxed
with 20C methanol for 10 minutes, incubated with 0.1%
Triton X-100 in PBS for 10 minutes, blocked (1% goat
serum, 0.05% NP40 in PBS) for 10 minutes, incubated with
primary antibody for 2 hours, incubated with ﬂuorophore-
tagged secondary antibodies for 1 hour in blocking solution,
and mounted with ProLong Gold anti-fade containing DAPI
(Life Technologies, Grand Island, NY).
Microscopy
Conventional light and phase-contrast microscopy and ﬂuo-
rescence microscopy used a Zeiss Axiovert microscope (Carl
Zeiss AG, Oberkochen, Germany) mounted with incandescent
and halogen lamps. Images were acquired and analyzed with
MetaMorph software version 6.5 (Molecular Devices, Down-
ington, PA). For confocal microscopy, images were acquired
with ZeissMeta Laser-Scanning ConfocalMicroscope System
(Zeiss AG) and Zen software 2009 (Carl Zeiss Microscopy,
LLC, Thornwood, NY). An argon laser exciting at 488 nm and
a redHeNe laser at 561 nmwere used to obtain optical sections.298Narrow-band emission ﬁlters were used to eliminate channel
cross talk. A 1.0-mm confocal aperture was used to obtain
z-plane sections. Slides were imagedwith a 63 oil immersion
Plan Apochromat objective lens (numerical aperture 1.4)
through a Zeiss Axiovert microscope. For time-lapse micros-
copy, images were acquired every 10 minutes with a Zeiss
Axiovert 200 microscope ﬁtted with a Yokogawa CSU 22
spinning disk (Yokogawa Corporation of America, Sugar
Land, TX) for time-lapse microscopy and a Photometrics
Cascade II camera (Photometrics, Tucson, AZ). Images were
analyzed by SlideBook software version 5.0 (Intelligent
Imaging Innovations, Inc., Denver, CO). For better visualiza-
tion of cells, we introduced GFP-tagged H2B using Celllight
H2B-GFP (Baculovirus).IHC and Histology
HeLa cells were washed with PBS, ﬁxed with formalin,
collected by scrapping, washed, and mixed with low-melting
agarose to form a plug, which was mounted in parafﬁn.
Immunohistochemistry (IHC)on sectionsused anti-FAM190A
antibody (mAb7) and Dako kit (Dako, Carpinteria, CA).
Human tissue and xenografts were ﬁxed in formalin and
mounted in parafﬁn. H&E sections were prepared for human
tissues, xenografts, and HeLa cell plugs.Phosphatase Treatment
HeLa cells were harvested in phosphatase lysis solution
(restriction enzyme1 buffer 3with1%TritonX;NewEngland
Biolab). After IP, washed beads containing captured protein
were resuspended in 1 buffer 3. CIP was added in either
sample type and incubated at 37C for 60 minutes. Laemmli
buffer was added to stop the reaction and for gel separation.Results
Natural and Induced Multinuclearity
As reported, focalmultinuclearitywas a pronounced feature of
a particular pancreatic exocrine adenocarcinoma (Figure 1A),4
which in another study was found to have an internal gene
rearrangement creating an out-of-frame deletion of exons 4
and 5 in the FAM190A gene.5
We generated several stable HeLa cell clones by trans-
fection of four different shRNA plasmids targeting the
FAM190A transcript. On screening the clones by IB, we
identiﬁed clone 77-2 (having integrated FAM190A shRNA
sequence 77) to have a very low FAM190A protein expres-
sion compared with control clone 03-1 (having control
shRNA plasmid) (Figure 1B). Focal multinuclear cells were
present in the culture of clone 77-2 but not in control clone 03-
1. OnH&E histologic examination of an agarose plug of clone
77-2 and clone 03-1, multiple isolated multinuclear cells were
again seen in the cells of the knockdown clone (Figure 1C).ajp.amjpathol.org - The American Journal of Pathology
Figure 1 Natural and induced multinuclearity
is induced by FAM190A absence. A: H&E-stained
section of a pancreatic cancer tissue with known
FAM190A exon 4 to 5 deletions. The tissue has focal
multinuclear cells (arrow). B: HeLa cell lines were
generated by stable transfection of control shRNA
plasmid or four different FAM190A-targeting shRNA
plasmids. FAM190A-targeting shRNA clone 77-2
had a reduced level of FAM190A protein compared
with control shRNA clone 03-1. IB with mAb7 and
antiea-tubulin. C: Agarose plugs were prepared
from two shRNA lines from B. Multinuclear cells
were present in clone 77-2 by H&E staining (arrow).
Control cells lacked multinuclearity. D: Phase-
contrast images of FAM190A-knockdown clone
77-2 and control cells. Multinuclear cells were
present in clone 77-2. E: Phase-contrast images
from a time-lapse movie of FAM190A-knockdown
clone 77-2 (Supplemental Video S1). A multinuclear
cell underwent multiple rounds of cell division,
generating progressively more nuclei in the cell
(arrow).
FAM190A Absence Creates Mitosis DefectsPhase-contrast microscopy conﬁrmed the presence of focal
cells having multiple nuclei in the FAM190A-knockdown
clone (Figure 1D). Some multinucleated cells had bizarre
nuclear shapes, as seen by DAPI staining (Supplemental
Figure S1A). We stained cells with PI and quantiﬁed DNA
by ﬂow cytometry. FAM190A-knockdown cells had a higher
fraction of cells having >2N DNA (percentage of cells,
means  SEM, 4.1  0.72) relative to control cells (1.10 
0.05; P < 0.05; Supplemental Figure S1B).
To visualize the process by which these cells became
multinuclear, we performed time-lapse microscopy. Cells
were imaged every 10 minutes. The resultant movies
revealed isolated mitotic cells failing to separate fully from
each other at cytokinesis. The unseparated cells sometimes
remained adjacent but eventually merged their cytoplasm
before synchronous mitosis, in the process forming a fused
cell with two or more nuclei. The multinucleated cells
underwent multipolar mitosis, failed to separate, and formed
cells with yet higher numbers of nuclei (Figure 1E and
Supplemental Videos S1, S2, S3, S4, S5, and S6). At times,
individual cells appeared to break away from the main massThe American Journal of Pathology - ajp.amjpathol.orgbut became detached or died. Cells with high numbers of
nuclei tended to become syncytial rather than retaining
a degree of separateness; thus, they resembled the giant cells
seen in some human cancers, the osteoclasts of normal bone,
and the cells in injured liver (multinucleate hepatocytes).
We used baculoviral infection to introduce GFP-tagged
H2B into clone 77-2. This permitted ﬂuorescence tracking
of the chromosomes and nuclei (Supplemental Videos S1,
S2, S3, S4, S5, and S6).
Multinucleate cell morphology was observed in replication
studies after stable transfection or infection of the same shRNA
plasmid. Multinucleate morphology was also observed in
multiple cell lines, including HeLa, RKO, 293-AAV, AsPC-1,
and DLD1, after stable transfection or infection of different
shRNA plasmids (Supplemental Figure S1C).
Cellular Localization
Immunoﬂuorescence
Rabbit monoclonal antibodies localized FAM190A to
the mitotic spindle in HeLa cells (Figure 2A). FAM190A299
Figure 2 FAM190A cellular localization suggests
mitotic functions. A: Representative confocal IF
images of HeLa cells at various cell cycle stages. Red,
FAM190A; green, a-tubulin; blue, DNA. B: Represen-
tative IF image of Flemming body of HeLa cells. Red,
FAM190A; green, a-tubulin. C: Representative IF
image ofmidbody of FAM190A-knockdown clone 77-2
and control cells. Red, FAM190A; green,a-tubulin. D:
Representative images from IHC of HeLa cells using
anti-FAM190Aantibody (mAb7), cells inmitosis. E: IB
comparing nuclear and cytoplasmic fractions of HeLa
cells. IBwithmAb7, antiea-tubulin, and antieLamin
B. C, cytoplasmic; N, nuclear; T, total. Scale bars: 5mm
(A); 1 mm (B and C).
Patel et alappeared in early prophase as a punctuate pattern, later
forming two dot-like foci. In metaphase, FAM190A appeared
as a purse stringelike structure, resembling tethering to
microtubules. FAM190A surrounded centrin 3 and g-tubulin
as a pericentriolarmaterial (Supplemental FigureS2,A andB).
In anaphase, the FAM190A ﬂuorescence intensity decreased
or dispersed, forming an arcuate structure at themitotic spindle
pole. There was faint signal between the planes of separated
chromosomes. FAM190A appeared as a ring structure at
the midbody (Figure 2B) in the late stage of cytokinesis
(Supplemental Figure S2C). Some FAM190A-knockdown
cells lacked FAM190A immunoﬂuorescence (IF) signal at
the midbody, including in cells undergoing multipolar mitosis
(Figure 2C). During interphase, FAM190A signal was low,
with ﬂuorescence seen faintly as nuclear speckles. FAM190A
similarly localized to the mitotic spindle andmidbody in other
cell lines, such as AAV-293, RKO, DLD1, and AsPC1
(Supplemental Figure S3A). Besides anti-FAM190A mono-
clonal antibodies, four FAM190A exon-speciﬁc rabbit poly-
clonal antibodies and two commercially available antibodies
also localized FAM190A at the mitotic spindle and midbody
(Supplemental Figure S3B).
We exogenously overexpressed FAM190A transiently
(see below), but GFP-tagged FAM190A produced a non-
physiologic diffuse pattern never observed in native cells.
Attempts to generateHeLa and 293 stable lines overexpressing
tagged FAM190A were unsuccessful. Long-term, rather than
short-term, overexpression of FAM190Amight be toxic to the
cells.
Immunohistochemistry
In HeLa cells, using an anti-FAM190A rabbit monoclonal
antibody, immunopositivity was seen at the spindle location300in mitotic cells (Figure 2D). We could determine neither late
telophase nor the midbody in these preparations.
Immunoblot
We prepared nuclear and cytoplasmic fractions of HeLa cells.
By IB, we found FAM190A exclusively in the nuclear
fraction (Figure 2E). In IBs of unfractionated cell lines, only
HeLa had an approximately 130-kDa band; this band was
depleted by shRNA targeting FAM190A (Supplemental
Figure S4A). This larger protein form was also present in
normal tissues (Supplemental Figure S4B), but the pancreatic
cancer xenografts lacked this band. The band was observed in
IB using other mAbs against FAM190A (Supplemental
Figures S4, S5, and S6). In histologic sections, xenografts
had high nuclear-to-cytoplasmic ratios, prominent nuclear
polymorphism, and atypia, and only PX-120 had occasional
multinuclear cells. The following experiments thus investi-
gated this protein species in HeLa cells. Exogenously
expressed untagged full-length FAM190A in transfected
cells was smaller in size than the upper band of native
FAM190A of HeLa cells, apparently having been processed
nonphysiologically. Moreover, FAM190A seems to be an
intrinsically unstructured protein. Intrinsically unstructured
proteins bind less SDS and appear 1.2 to 1.8 times higher
than calculated molecular weight in SDS-PAGE gels12;
FAM190A was seen at approximately 130 kDa than the
calculated molecular weight of approximately 100 kDa.
FAM190A Changes During the Cell Cycle
In IBs of HeLa cells treated with the microtubule polymeri-
zation inhibitors nocodazole or demecolcine, FAM190A
became a slower-migrating isoform (Figure 3A), owing toajp.amjpathol.org - The American Journal of Pathology
Figure 3 FAM190A changes during cell cycle.
A: HeLa cells were treated with nocodazole for 16
hours or demecolcine for 24 hours. After microtu-
bule depolymerizing drugs, FAM190A migrated
slower. IB with mAb7 and antiea-actin. B and C:
HeLa cells were treated with nocodazole for 16
hours. At different times after drug washout, cells
were prepared for IF. FAM190A foci were counted at
different times. 0 foci, cells at interphase; 2 foci,
cells in mitosis; >2 foci, cells under nocodazole
effect or ongoing redistribution of FAM190A after
drug release. nZ foci counted from total number of
cells at a time point. D: HeLa cells were synchro-
nized at prometaphase by nocodazole preceded by
thymidine block. Cells were harvested at different
points after release from nocodazole and examined
by IB. IB withmAb170, antiecyclin E, antiesecurin
B, and anti-GAPDH. TN, thymidine-nocodazole
block. E: HeLa cells were synchronized at G1/S-
phase by double thymidine block. Cells were har-
vested at different times after release from block
and examined by IB. IB with mAb170, antiecyclin
E, antiesecurin B, and anti-GAPDH. DT, double
thymidine block. Scale barZ 5 mm (B and C).
FAM190A Absence Creates Mitosis Defectsprotein phosphorylation. To determine the subcellular
manifestation of this change, we examined cells treated with
nocodazole for 16 hours and cells at postrelease time points
after nocodazole washout by IF. In arrested cells, FAM190A
appeared as a punctuate pattern (multiple foci per cell) with
an intense ﬂuorescence. After release, multiple foci became
rearranged to form two foci per cell at the spindle poles
during mitosis and became nearly unapparent as cells entered
interphase (Figure 3B). Cell cycle progression after noco-
dazole wash was followed by counting FAM190A foci per
cell at various time points (Figure 3C). FAM190A was co-
localized with microtubules (a-tubulin) at spindle poles
from prometaphase to anaphase.
We synchronized HeLa cells at prometaphase by a thymi-
dine-nocodazole block and harvested samples at various time
points after drug washout. By IB, we observed the slower-
migrating forms of FAM190A during the nocodazole block,
but on release it disappeared by approximately 2 hours, when
the native (faster-migrating) isoform progressively appeared,
returning to the isoform pattern observed in the unsynchro-
nized cells (Figure 3D). The timing of the disappearance of
the slower isoform coincided with the timing of degradation
of securin B and reappearance of cyclin E in the same cells,
which are time posts of cell cycle progression.13,14 The cell
cycle progression of blocked and released cells were also
determined by ﬂow cytometry (Supplemental Figure S5A).
Mixing of samples revealed the two species of FAM190A
were indeed distinct (Supplemental Figure S5B).
On synchronizing cells at G1/S-phase by double thymidine
block, the levels of FAM190A protein had a pronounced
decrease compared with unsynchronized cells. After release,
levels of FAM190A protein increased, peaked in M-phase
at 12 hours, and subsequently decreased (Figure 3E). Cell cycle
progression was determined by ﬂow cytometry (Supplemental
Figure S5A). A pronounced decrease in FAM190A proteinThe American Journal of Pathology - ajp.amjpathol.orgalso occurred by 48 hours after serum starvation, and an
increase occurred after the readdition of serum to the culture
(Supplemental Figure S5C).
FAM190A Interactome
Several FAM190A-interacting proteins were suggested by the
yeast two-hybrid screen (Supplemental Table S1). We veriﬁed
Ndel1 and EXOC1 as binding partners of FAM190A by IP
(Figure 4). The Ndel1 inverse interaction with FAM190A was
previously reported using Ndel1 as the yeast two-hybrid bait.15
Ndel1 plays a role in cytoskeletal organization and neuronal
migration.16 EXOC1 is a part of the exocyst complex, partic-
ipates in actin cytoskeletal remodeling and vesicular trans-
port,17 and plays an important role in mediating the cargo
transport of proteins to the midbody during cytokinesis.18
FAM190A Isoforms in Mitosis
We treated HeLa cells with MG132, which inhibits S26
proteasomal protein degradation. After MG132 treatment,
levels of FAM190A protein were modestly increased and
the slow-migrating form of FAM190A appeared (Figure 5A).
It is possible that the mitotic arrest indirectly induced by
MG132 mimicked the arrest earlier observed by nocodazole
and demecolcine, preventing the mitotic degradation of
FAM190A protein as suggested in earlier experiments.
Using IP, we captured FAM190A from HeLa cells
synchronized by nocodazole, cells synchronized by nocoda-
zole and treatedwithMG132 for 4 hours, and unsynchronized
cells. Captured protein was treated with CIP. CIP-treated
FAM190A converted to a fast-migrating form, indicating that
the slower-migrating isoform of M-phaseearrested cells and
even the FAM190A isoform in unsynchronized cells were
phosphorylated species of FAM190A (Figure 5B).301
Figure 4 FAM190A interacts with EXOC1 and Ndel1. FAM190A was
captured with mAb170 and mAb62. FAM190A, EXOC1, and Ndel1 were
identiﬁed in captured proteins by IB. IP by rabbit IgG is a control.
Patel et alTo examine the difference in the phosphorylation isoforms,
we compared unsynchronized cells, cells synchronized by
double thymidine block (G0/G1-phase), cells synchronized by
double thymidine block and released for 2 hours (S-phase), and
cells synchronized by thymidine-nocodazole block (M-phase)
by IB.We found progressively slowermigration of FAM190A
from G0/G1-phase, S-phase, to M-phase (Figure 5C).
FAM190A at S-phase was phosphorylated because CIP treat-
ment increased its gel migration (Supplemental Figure S6, A
and B). FAM190A was phosphorylated in HeLa cells after
release from thymidine block (Supplemental Figure S6A) and
after release fromserum starvation (Supplemental FigureS6B).
Thus, the phosphorylated FAM190A form accumulating
before M-phase existed independent of nocodazole, although
FAM190A in nocodazole-arrested cells had a slowermigration
than in S-phase, apparently due to additional phosphorylation.Figure 5 FAM190A is phosphorylated in mitosis. A: HeLa cells were
incubated with MG132 for 4 hours and 6 hours and harvested in lysis solu-
tion. IB with mAb7 and antiea-tubulin. B: HeLa cells were synchronized at
prometaphase by nocodazole or released into MG132 after nocodazole block
for 4 hours. FAM190A was captured with mAb170 and mAb62 and incubated
with or without CIP for 60 minutes at 37C. IB using mAb170. C: HeLa cells
were synchronized to a different phase of cell cycle by double thymidine
block (G1/S-phase), 2-hour release after double thymidine block (S-phase),
or thymidine-nocodazole block (M-phase). Lysates were treated with CIP for
60 minutes. IB with mAb170 and mAb62 and a-tubulin. Un, unsynchronized
cells. The arrowhead indicates a nonspeciﬁc band.Discussion
Theodor Boveri proposed that aberrant multipolar mitosis
might generate the abnormal chromatin ﬁndings of cancers.19
He wrote, “When I published the results of my experiments
on the development of double-fertilized sea-urchin eggs in
1902, I added the suggestion that malignant tumors might be
the result of a certain abnormal condition of the chromo-
somes, which may arise from multipolar mitosis. So I have
carried on for a long time the kind of experiments I suggested,
which are so far without success, but my conviction remains
unshaken.” Since his proposal, the overexpression of aurora
kinases has been one of the potential mechanisms suggested
to form multipolar mitotic division in cancer.20,21
We present novel characteristics of the FAM190A gene,
which is frequently altered in human cancers but had an
unknown function. A pancreatic cancer with foci of multi-
nuclear cells was previously described to have an unusually
early and out-of-frame FAM190A deletion/rearrangement.
Human tumors and cancer cell lines often had an absence of
the larger protein form that was otherwise observed in normal
human tissues (Supplemental Figure S4B) and in FAM190A
wild-type HeLa cells. In cellular studies, FAM190A was
present in the nuclear fraction of unsynchronized populations,
but its form and quantity were modiﬁed and potentially
regulated by posttranslational modiﬁcation, during the cell
division cycle. At S-phase and in mitotic arrest, transient
phosphorylated isoforms appeared. FAM190A localized to302early and latemitotic structures, including the Flemming body
of the cytokinesis midbody structure.
FAM190A had protein interactions with EXOC1 and
Ndel1. EXOC1 is a core component of the exocyst complex,
which transports proteins and lipids to cell membrane
destinations, including the midbody,22,23 where exocyst
function and endosomal trafﬁcking are required for cytoki-
nesis.18 Ndel1 participates in dynein-dependent and dynein-
independent centrosomal protein assembly.24
We induced cytokinetic defects and multipolar asynchro-
nous division of multinuclear cells on the depletion of
FAM190A. We propose that FAM190A normally plays
essential structural or regulatory roles in mitosis. This role is
especially likely at the midbody, where interactions of
FAM190A with the exocyst complex may be required for
normal cytokinesis. In the absence of adequate FAM190A
function, abscission fails, eventually yielding multinuclearity
and several multipolar mitotic cycles.
We speculate that the focal nature of the multinuclear
cells in both the cited pancreatic cancer and in our cellular
FAM190A-knockdown model may represent a threshold
effect. There might exist a functional level below which a
cell experiences negative selective pressures due to a severe
FAM190A deﬁciency (creating a multinuclear phenotype),ajp.amjpathol.org - The American Journal of Pathology
FAM190A Absence Creates Mitosis Defectsin turn limiting the tolerated number of generations of
aberrant multipolar cell division and causing cell death.
Other cells might tolerate having low FAM190A. Some of
these will occasionally decrease below the threshold of
FAM190A expression level, creating a dynamic equilibrium
of multinuclear cells at approximately 4% to 5% of the total
cells after FAM190A knockdown. On the basis of our
knockdown model, we further speculate that there would be
a focal and transient presence of multinuclear cells in human
tumors rather than the whole tumor having multinuclear cells.
The predicted formation of truncated and internally
deleted proteins requires that we consider the possibility of
dominant-negative effects of any altered FAM190A proteins,
helping to explain the co-existence in many tumors of
a single deleted FAM190A transcript structure with a wild-
type transcript.6 We thus also suggest that the more common
in-frame homozygous deletions and deletion/rearrangements
of FAM190A transcripts in cancers create analogous, yet
more subtle, mitotic defects, which contribute to genetic
instability during tumorigenesis.
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